** Shares of digital healthcare services platform Phreesia PHR.N rise as much as 4.2% to $28.10, the highest since February 2024
** Brokerage RBC Capital Markets upgrades the stock to "outperform" from "sector perform", raises PT by $8 to $32
** Sees company's average revenue per client growth accelerating, on increasing Network Solutions segment momentum, cross-selling of several newer provider add-ons and signing of new clients with bigger initial solution bundles
** Also sees company's operating cost base remaining stable, and helping to generate significant operating leverage
** Fifteen brokerages rate the stock "buy" or higher; with a median PT of $30, according to data compiled by LSEG
** PHR sales rose 8.7% last year
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。